pharmafileMarch 05, 2018
Tag: Diabetes
A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic distinction between type 1 and 2 diabetes was shown to need some revision.
Researchers from Lund University Diabetes Centre monitored 13,720 newly diagnosed patients, of between the ages 18 and 97, from 2008 onwards; along the way, certain measurements were taken, including insulin resistance, insulin secretion, blood sugar levels and age at onset of illness.
Through analysis, scientists were able to observe five distinct types of diabetes, which they grouped as follows:
At present, people are currently only separated into type 1, which make up around 10% of those living with diabetes, and type 2, which makes up the further 90%.
Type 1 is classed into group 1 and type 2 is then broken down into four different categories.
As mentioned by Groop, the potential for the study to change guidelines for treatment in the future is huge, especially in Group 2, which is very similar to traditional type 1 diabetes and requires those living with this sub-type to receive insulin early after diagnosis for best management of their condition.
A drawback of the study was that the population groups were limited to Sweden and Finland, potentially leaving out various other forms of diabetes.
Prevalence of diabetes is known to differ geographically, indicating that there are gene mutations that could increase the likelihood of certain types of diabetes specific to certain regions.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: